US Stock Market Move | Navan (NAVN.US) is listed on the US stock market, and its opening stock price has fallen.
As of the time of writing, the stock has fallen more than 15%, trading at $21.1.
On Thursday, the enterprise travel and expense management platform Navan (NAVN.US) made its debut on the US stock market, opening with a drop in stock price. As of the time of reporting, the stock has fallen by over 15%, trading at 21.1 US dollars. The IPO price was 25 US dollars. Navan was founded by Ariel Cohen and Ilan Twig in 2015, initially named TripActions, with its core business being enterprise travel management. The company was established with the goal of revolutionizing the traditional travel services model, which was previously mainly provided by companies such as American Express Company (AXP.US) and SAP Concur. According to information on the Navan official website, over the years, the company has expanded its business to enterprise payment and expense management, serving global customers including Zoom Communications (ZM.US) and Lyft (LYFT.US).
 Related Articles 

Gansu Shangfeng Cement (000672.SZ) joint venture company Shenghe Jingwei Micro Science and Technology Innovation Board IPO application has been accepted.

Pre-market broadcast of A shares | Cloud business achieved the fastest growth in three years! Amazon rose 14% after hours. China and the United States reached consensus on multiple achievements in economic and trade negotiations.

The phase 1/2 clinical data for the cancer candidate drug is positive, causing the stock price of Intensity Therapeutics (INTS.US) to surge by 395%.
Gansu Shangfeng Cement (000672.SZ) joint venture company Shenghe Jingwei Micro Science and Technology Innovation Board IPO application has been accepted.

Pre-market broadcast of A shares | Cloud business achieved the fastest growth in three years! Amazon rose 14% after hours. China and the United States reached consensus on multiple achievements in economic and trade negotiations.

The phase 1/2 clinical data for the cancer candidate drug is positive, causing the stock price of Intensity Therapeutics (INTS.US) to surge by 395%.

RECOMMEND

First in History: NVIDIA’s Market Capitalization Tops $5 Trillion
30/10/2025

Congressional Budget Office Estimates Government Shutdown Has Cost the U.S. Economy $18 Billion
30/10/2025

Wall Street on China’s Internet Sector: Distinct Investment Opportunities in AI and Gaming; Caution on E‑commerce
30/10/2025


